QQQ   273.53 (+2.35%)
AAPL   142.45 (+3.08%)
MSFT   240.74 (+3.37%)
META   138.61 (+2.16%)
GOOGL   98.64 (+3.13%)
AMZN   115.88 (+2.55%)
TSLA   242.40 (-8.61%)
NVDA   125.12 (+3.07%)
NIO   15.49 (-1.78%)
BABA   80.45 (+0.58%)
AMD   66.11 (+4.34%)
T   15.90 (+3.65%)
MU   51.72 (+3.23%)
CGC   2.91 (+6.59%)
F   11.47 (+2.41%)
GE   63.60 (+2.73%)
DIS   97.13 (+2.97%)
AMC   6.88 (-1.29%)
PYPL   87.18 (+1.29%)
PFE   44.14 (+0.87%)
NFLX   239.04 (+1.53%)
QQQ   273.53 (+2.35%)
AAPL   142.45 (+3.08%)
MSFT   240.74 (+3.37%)
META   138.61 (+2.16%)
GOOGL   98.64 (+3.13%)
AMZN   115.88 (+2.55%)
TSLA   242.40 (-8.61%)
NVDA   125.12 (+3.07%)
NIO   15.49 (-1.78%)
BABA   80.45 (+0.58%)
AMD   66.11 (+4.34%)
T   15.90 (+3.65%)
MU   51.72 (+3.23%)
CGC   2.91 (+6.59%)
F   11.47 (+2.41%)
GE   63.60 (+2.73%)
DIS   97.13 (+2.97%)
AMC   6.88 (-1.29%)
PYPL   87.18 (+1.29%)
PFE   44.14 (+0.87%)
NFLX   239.04 (+1.53%)
QQQ   273.53 (+2.35%)
AAPL   142.45 (+3.08%)
MSFT   240.74 (+3.37%)
META   138.61 (+2.16%)
GOOGL   98.64 (+3.13%)
AMZN   115.88 (+2.55%)
TSLA   242.40 (-8.61%)
NVDA   125.12 (+3.07%)
NIO   15.49 (-1.78%)
BABA   80.45 (+0.58%)
AMD   66.11 (+4.34%)
T   15.90 (+3.65%)
MU   51.72 (+3.23%)
CGC   2.91 (+6.59%)
F   11.47 (+2.41%)
GE   63.60 (+2.73%)
DIS   97.13 (+2.97%)
AMC   6.88 (-1.29%)
PYPL   87.18 (+1.29%)
PFE   44.14 (+0.87%)
NFLX   239.04 (+1.53%)
QQQ   273.53 (+2.35%)
AAPL   142.45 (+3.08%)
MSFT   240.74 (+3.37%)
META   138.61 (+2.16%)
GOOGL   98.64 (+3.13%)
AMZN   115.88 (+2.55%)
TSLA   242.40 (-8.61%)
NVDA   125.12 (+3.07%)
NIO   15.49 (-1.78%)
BABA   80.45 (+0.58%)
AMD   66.11 (+4.34%)
T   15.90 (+3.65%)
MU   51.72 (+3.23%)
CGC   2.91 (+6.59%)
F   11.47 (+2.41%)
GE   63.60 (+2.73%)
DIS   97.13 (+2.97%)
AMC   6.88 (-1.29%)
PYPL   87.18 (+1.29%)
PFE   44.14 (+0.87%)
NFLX   239.04 (+1.53%)
NASDAQ:EXPO

Exponent - EXPO Stock Forecast, Price & News

$89.69
+2.02 (+2.30%)
(As of 10/3/2022 12:00 AM ET)
Add
Compare
Today's Range
$88.50
$90.35
50-Day Range
$87.67
$104.14
52-Week Range
$80.97
$127.61
Volume
144,217 shs
Average Volume
246,125 shs
Market Capitalization
$4.65 billion
P/E Ratio
47.46
Dividend Yield
1.10%
Price Target
$120.00

Exponent MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
33.8% Upside
$120.00 Price Target
Short Interest
Bearish
2.91% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
0.28mentions of Exponent in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$1.17 M Sold Last Quarter
Proj. Earnings Growth
10.27%
From $1.85 to $2.04 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.70 out of 5 stars

Business Services Sector

50th out of 335 stocks

Management Consulting Services Industry

3rd out of 19 stocks

EXPO stock logo

About Exponent (NASDAQ:EXPO) Stock

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. It operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.

Receive EXPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exponent and its competitors with MarketBeat's FREE daily newsletter.

EXPO Stock News Headlines

Exponent: Q2 Earnings Snapshot - Greenwich Time
Exponent (EXPO) Q2 Earnings Surpass Estimates
Exponent: Q2 Earnings Insights - Benzinga
See More Headlines
Receive EXPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exponent and its competitors with MarketBeat's FREE daily newsletter.

EXPO Company Calendar

Last Earnings
7/28/2022
Ex-Dividend for 9/23 Dividend
9/08/2022
Dividend Payable
9/23/2022
Today
10/03/2022
Next Earnings (Estimated)
10/27/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Management consulting services
Sub-Industry
Research & Consulting Services
Current Symbol
NASDAQ:EXPO
CUSIP
30214U10
Employees
1,215
Year Founded
1967

Price Target and Rating

Average Stock Price Forecast
$120.00
High Stock Price Forecast
$120.00
Low Stock Price Forecast
$120.00
Forecasted Upside/Downside
+33.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$101.20 million
Pretax Margin
26.46%

Debt

Sales & Book Value

Annual Sales
$466.27 million
Cash Flow
$1.92 per share
Book Value
$8.00 per share

Miscellaneous

Free Float
50,786,000
Market Cap
$4.65 billion
Optionable
Optionable
Beta
0.61

Social Links


Key Executives

  • Dr. Catherine Ford Corrigan P.E. (Age 53)
    Ph.D., Pres, CEO & Director
    Comp: $1.72M
  • Mr. Richard L. Schlenker Jr.Mr. Richard L. Schlenker Jr. (Age 56)
    Exec. VP, CFO & Corp. Sec.
    Comp: $1.11M
  • Dr. Maureen T. F. Reitman Sc.D. (Age 53)
    F.S.P.E., P.E., Corp. VP - Polymers Science & Materials Chemistry, Principal Engineer and Practice Director
    Comp: $945.06k
  • Dr. Steven J. Murray P.E.Dr. Steven J. Murray P.E. (Age 47)
    Ph.D., Group VP & Principal Engineer
    Comp: $928.25k
  • Dr. Bernard Ross
    Co-Founder, Chairman Emeritus & Principal Engineer
  • Dr. Subbaiah V. Malladi (Age 75)
    CTO & Principal Engineer
  • Ms. Sally B. ShepardMs. Sally B. Shepard (Age 61)
    Chief HR Officer
  • Mr. Eric R. Anderson
    VP & Corp. Controller
  • Dr. Robert D. Caligiuri FASM (Age 70)
    P.E., Ph.D., Corp. VP of Materials & Corrosion Engineering and Principal Engineer
  • Dr. Paul D. Boehm Ph.D. (Age 73)
    Corp. VP of Environmental & Health Sciences and Principal Scientist













EXPO Stock - Frequently Asked Questions

Should I buy or sell Exponent stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Exponent in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" EXPO shares.
View EXPO analyst ratings
or view top-rated stocks.

What is Exponent's stock price forecast for 2022?

1 Wall Street analysts have issued twelve-month target prices for Exponent's shares. Their EXPO share price forecasts range from $120.00 to $120.00. On average, they anticipate the company's share price to reach $120.00 in the next twelve months. This suggests a possible upside of 33.4% from the stock's current price.
View analysts price targets for EXPO
or view top-rated stocks among Wall Street analysts.

How have EXPO shares performed in 2022?

Exponent's stock was trading at $116.73 at the beginning of the year. Since then, EXPO stock has decreased by 22.9% and is now trading at $89.95.
View the best growth stocks for 2022 here
.

When is Exponent's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 27th 2022.
View our EXPO earnings forecast
.

How were Exponent's earnings last quarter?

Exponent, Inc. (NASDAQ:EXPO) announced its quarterly earnings results on Thursday, July, 28th. The business services provider reported $0.49 EPS for the quarter, beating analysts' consensus estimates of $0.45 by $0.04. The business services provider had revenue of $130.28 million for the quarter, compared to analysts' expectations of $118.53 million. Exponent had a trailing twelve-month return on equity of 25.93% and a net margin of 20.53%. Exponent's revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.48 earnings per share.

How often does Exponent pay dividends? What is the dividend yield for Exponent?

Exponent declared a quarterly dividend on Thursday, July 28th. Shareholders of record on Friday, September 9th will be paid a dividend of $0.24 per share on Friday, September 23rd. This represents a $0.96 annualized dividend and a yield of 1.07%. The ex-dividend date of this dividend is Thursday, September 8th.
Read our dividend analysis for EXPO
.

Is Exponent a good dividend stock?

Exponent (NASDAQ:EXPO) pays an annual dividend of $0.96 per share and currently has a dividend yield of 1.10%. The company has been increasing its dividend for 4 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 50.79%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, EXPO will have a dividend payout ratio of 47.06% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for EXPO.

When did Exponent's stock split?

Exponent shares split on Thursday, June 7th 2018. The 2-1 split was announced on Tuesday, May 15th 2018. The newly created shares were distributed to shareholders after the closing bell on Wednesday, June 6th 2018. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

What is Catherine Corrigan's approval rating as Exponent's CEO?

15 employees have rated Exponent Chief Executive Officer Catherine Corrigan on Glassdoor.com. Catherine Corrigan has an approval rating of 84% among the company's employees.

What other stocks do shareholders of Exponent own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Exponent investors own include AbbVie (ABBV), Pfizer (PFE), Abbott Laboratories (ABT), Energy Transfer (ET), Ford Motor (F), Micron Technology (MU), AT&T (T), UnitedHealth Group (UNH), Visa (V) and Adobe (ADBE).

What is Exponent's stock symbol?

Exponent trades on the NASDAQ under the ticker symbol "EXPO."

How do I buy shares of Exponent?

Shares of EXPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Exponent's stock price today?

One share of EXPO stock can currently be purchased for approximately $89.95.

How much money does Exponent make?

Exponent (NASDAQ:EXPO) has a market capitalization of $4.66 billion and generates $466.27 million in revenue each year. The business services provider earns $101.20 million in net income (profit) each year or $1.89 on an earnings per share basis.

How many employees does Exponent have?

The company employs 1,215 workers across the globe.

Does Exponent have any subsidiaries?
The following companies are subsidiares of Exponent: Dennis Publishing.
Read More
How can I contact Exponent?

Exponent's mailing address is 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025. The official website for the company is www.exponent.com. The business services provider can be reached via phone at (650) 326-9400, via email at investor-relations@exponent.com, or via fax at 650-326-8072.

This page (NASDAQ:EXPO) was last updated on 10/3/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.